๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Inflammatory Myopathy

Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES NCT07265999n/a1 site๐Ÿ“ Pointe-ร -Pitre Centre Hospitalier Universitaire de la Guadeloupe An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 Rare AutoImmune SElf-management Programme Development NCT06642870n/a1 site๐Ÿ“ Bristol University of the West of England ยท Tests: Non-interventional study Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases NCT07558850NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: anti-CD19/BCMA-UCAR-T cells Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD19- BCMA CAR-T cells CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP) NCT06089616n/a5 sites๐Ÿ“ San Francisco๐Ÿ“ Philadelphia๐Ÿ“ Edmonton Ipsen Adult and Juvenile Myositis NCT00017914n/a4 sites๐Ÿ“ Atlanta๐Ÿ“ Bethesda๐Ÿ“ Research Triangle Park National Institute of Environmental Health Sciences (NIEHS) Rheumatology Diet Study NCT06339957n/a1 site๐Ÿ“ Orlando University of Central Florida Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) NCT06686524Phase 11 site๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: Anti-CD19 UCAR-T cells Safety and Efficacy of Universal CD19-targeting CAR-ฮณฮดT Cells in Refractory Autoimmune Diseases NCT06828042Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: anti-CD19 CAR T cell therapy Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases NCT06685042Phase 1, Phase 21 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: CAR T cell Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic NCT06460142n/a1 site๐Ÿ“ Bonn University of Bonn ยท Tests: Aortic/ cardiac magnetic resonance imaging, Vascular ultrasound, Transorbital Ultrasound, Contrast-Enhanced Ultrasound,โ€ฆ CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) Panniculitis in Dermatomyositis NCT07345949n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) NCT06733935Phase 1, Phase 218 sites๐Ÿ“ Orange๐Ÿ“ Gainesville๐Ÿ“ Miami Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Inspiratory Muscle Training in Patients With Inflammatory Myopathy NCT07274267NA1 site๐Ÿ“ Warsaw Jรณzef Piล‚sudski University of Physical Education ยท Tests: Inspiratory Muscle Training (IMT) Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450Phase 11 site๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: BCMA/CD70-targetd CAR-T MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) NCT07374107n/a1 site๐Ÿ“ New Orleans Myositis International Health & Research Collaborative Alliโ€ฆ ยท Tests: No intervention - qualitative and mixed methods investigations Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) NCT07160205Phase 2, Phase 32 sites๐Ÿ“ Gainesville๐Ÿ“ Miami Restem, LLC. ยท Tests: ULSC (1.5 x 10^8 cells/dose), Placebo (no cells) Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases NCT06599411n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Sampling, Sampling A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site๐Ÿ“ Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell Investigation of the Validity, Reliability, and Responsiveness of the BETY-BQ in Myositis NCT06587724n/a1 site๐Ÿ“ Ankara Hacettepe University ยท Tests: Questionnaire study Optimizing Treatment on Idiopathic Inflammatory Myopathies NCT03092180n/a1 site๐Ÿ“ Sรฃo Paulo University of Sao Paulo ยท Tests: Intravenous Infusion Electroacupuncture Pain Treatment, Mechanical Hyperalgesia, Quality of Life & Expression of Mu+ B Cells in Fibromyalgia NCT05357157n/a1 site๐Ÿ“ Heraklion University of Crete ยท Tests: Electroacupuncture, Nutrition, Dietary supplement Environmental Risk Factors for the Anti-synthetase Syndrome NCT01276470n/a8 sites๐Ÿ“ Miami๐Ÿ“ Baltimore๐Ÿ“ Bethesda National Institute of Environmental Health Sciences (NIEHS) A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies NCT06698796Phase 326 sites๐Ÿ“ Glendale๐Ÿ“ Frisco๐Ÿ“ Houston Pfizer ยท Tests: Dazukibart Rheumatology Patient Registry and Biorepository NCT04402086n/a1 site๐Ÿ“ New Haven Yale University
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy